Literature DB >> 12628708

Synthesis and antitumor activity of cyclopentadienyltitanium substituted polyoxotungstate [CoW11O39(CpTi)]7- (Cp=eta5-C5H5).

Xiaohong Wang1, Jingfu Liu, Jianxin Li, Yong Yang, Jutao Liu, Bin Li, Michael T Pope.   

Abstract

A novel polyoxotungstate [CoW(11)O(39)(CpTi)](7-) (Cp=eta(5)-C(5)H(5)) has been prepared. This complex exhibits the highest antitumor activity in vitro among the cyclopentadienyltitanium substituted polyoxometalates investigated and has a remarkable inhibitory action on three types of human cancer cells, SSMC-7721, HL-60 and HLC, in vivo. Copyright 2003 Elsevier Science Inc.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12628708     DOI： 10.1016/s0162-0134(02)00631-1

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN： 0162-0134            Impact factor:   4.155


  7 in total

1.  Anticancer Activity of Polyoxometalate-Bisphosphonate Complexes: Synthesis, Characterization, In Vitro and In Vivo Results.

Authors:  Amandine Boulmier; Xinxin Feng; Olivier Oms; Pierre Mialane; Eric Rivière; Christopher J Shin; Jiaqi Yao; Tadahiko Kubo; Taisuke Furuta; Eric Oldfield; Anne Dolbecq
Journal:  Inorg Chem       Date:  2017-06-20       Impact factor: 5.165

2.  Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.

Authors:  Hongqian Cao; Chunyan Li; Wen Qi; Xiangjun Meng; Rui Tian; Yanfei Qi; Wei Yang; Juan Li
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

3.  Cation-mediated optical resolution and anticancer activity of chiral polyoxometalates built from entirely achiral building blocks.

Authors:  Zhi-Ming Zhang; Xiaopin Duan; Shuang Yao; Zhishu Wang; Zekai Lin; Yang-Guang Li; La-Sheng Long; En-Bo Wang; Wenbin Lin
Journal:  Chem Sci       Date:  2016-03-09       Impact factor: 9.825

4.  Selective Targeting of Proteins by Hybrid Polyoxometalates: Interaction Between a Bis-Biotinylated Hybrid Conjugate and Avidin.

Authors:  Valeria A Zamolo; Gloria Modugno; Elisa Lubian; Alessandro Cazzolaro; Fabrizio Mancin; Livia Giotta; Disma Mastrogiacomo; Ludovico Valli; Alessandra Saccani; Silke Krol; Marcella Bonchio; Mauro Carraro
Journal:  Front Chem       Date:  2018-07-11       Impact factor: 5.221

5.  In vivo toxicity evaluation of two polyoxotungstates with potential antidiabetic activity using Wistar rats as a model system.

Authors:  Marko Dinčić; Mirjana B Čolović; Marija Sarić Matutinović; Mila Ćetković; Tamara Kravić Stevović; Ali S Mougharbel; Jasna Todorović; Svetlana Ignjatović; Branimir Radosavljević; Milan Milisavljević; Ulrich Kortz; Danijela Z Krstić
Journal:  RSC Adv       Date:  2020-01-15       Impact factor: 3.361

Review 6.  Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease.

Authors:  Xuechen Wang; Shengnan Wei; Chao Zhao; Xin Li; Jin Jin; Xuening Shi; Zhenyue Su; Juan Li; Juan Wang
Journal:  J Biol Inorg Chem       Date:  2022-06-17       Impact factor: 3.862

Review 7.  Polyoxometalates as Potential Next-Generation Metallodrugs in the Combat Against Cancer.

Authors:  Aleksandar Bijelic; Manuel Aureliano; Annette Rompel
Journal:  Angew Chem Int Ed Engl       Date:  2018-10-12       Impact factor: 15.336
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.